Key Insights

Highlights

Success Rate

87% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.0%

5 terminated out of 100 trials

Success Rate

86.8%

+0.3% vs benchmark

Late-Stage Pipeline

11%

11 trials in Phase 3/4

Results Transparency

24%

8 of 33 completed with results

Key Signals

8 with results87% success

Data Visualizations

Phase Distribution

69Total
Not Applicable (24)
Early P 1 (3)
P 1 (8)
P 2 (23)
P 3 (8)
P 4 (3)

Trial Status

Completed33
Unknown24
Recruiting18
Withdrawn7
Not Yet Recruiting7
Active Not Recruiting6

Trial Success Rate

86.8%

Benchmark: 86.5%

Based on 33 completed trials

Clinical Trials (100)

Showing 20 of 20 trials
NCT07563010Phase 2Not Yet Recruiting

Menin-Inhibitor Targeted Maintenance in AML

NCT03214354Phase 2Recruiting

Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

NCT04554914Phase 2Active Not Recruiting

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

NCT06160986Not ApplicableActive Not Recruiting

Horizons Chronic Graft-Versus-Host-Disease Study

NCT06541002Not ApplicableRecruiting

A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors

NCT04623424RecruitingPrimary

Intestinal Microbiota in Stem Cell Transplant Transplant Admission

NCT03394365Phase 3Recruiting

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

NCT05421416Phase 2RecruitingPrimary

Loratadine for the Prevention of G-CSF-related Bone Pain

NCT05706766Not ApplicableRecruiting

Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

NCT07358195Early Phase 1Not Yet Recruiting

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

NCT04479995Not ApplicableActive Not RecruitingPrimary

Multidisciplinary Intervention In Chronic GVHD

NCT07340723Phase 2Recruiting

Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease )

NCT03454568CompletedPrimary

The Patients' Experience After Stem Cell Transplant

NCT03865589Not ApplicableActive Not Recruiting

Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome

NCT04167683Active Not Recruiting

Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant

NCT05466201Phase 2CompletedPrimary

The Use of Eltrombopag Post HSCT in BMFD

NCT04937400Active Not RecruitingPrimary

Delirium in Children Undergoing Stem Cell Transplantation

NCT04678401Phase 1RecruitingPrimary

IS-free Treg HaploHCT

NCT03850379Phase 2Completed

Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant

NCT04655508Phase 3TerminatedPrimary

Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation

Scroll to load more

Research Network

Activity Timeline